The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension

European Journal of Preventive Cardiology

11 May 2021
Organised by: Logo
ESC Journals

Abstract

AbstractFunding Acknowledgements

Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Agency for Research an Development

OnBehalf

HIPERDIAB

Background

Increased blood pressure is considered the major determinant for structural alterations of the left ventricle resulting in increased myocardial mass and pathological remodeling. Renal denervation is a novel treatment for hypertensive patients with promising results on blood pressure levels.

Purpose

Evaluation of impact of renal denervation treatment on indices of left ventricular remodeling in patients with resistant hypertension.

Methods

75 patients with resistant hypertension  after a 3-week standardized treatment with Losartan 100 mg, Amlodipine 10 mg and Indapamid 1,5 mg were randomly assigned into three equal groups, depending on medication supplemented to previously administered: IM group -  Moxonidine, IIB group - Bisoprolol and IIID group – renal artery denervation (RDN). Patients were assessed by echocardiographic exam at baseline and 6 months follow-up. Renal denervation was performed with a Symplicity Spyral catheter.

Results

Increased at the baseline in all three groups (170,96 ± 11,69 g/m2  in IM versus 156,5 ± 11,08 g/m2  in IIB and 164,94 ± 9,61 g/m2  in IIID groups) left ventricular mass index at 6 months of evaluation noted a statistically authentic reduction in all three groups, the group of patients treated with Moxonidine and RDN having a comparable and superior effect to the group treated with Bisoprolol (159,02 ± 10,34 g/m2 versus 150,5 ± 10,51 g/m2 and 149,15 ± 9,31 g/m2 in IM, IIB and IIID groups, p > 0,05).

Simultaniously with the regression of left ventricular myocardial hypertrophy all three treatment regimens induced the improvement of its geometry, renal denervation group demonstrated a superior effect in ameliorating of this parameter (Tab.).

Conclusion

The data obtained confirmed the benefit of RDN treatment in patients with resistant hypertension in inducing reverse-remodeling of the LV, the beneficial effect being superior to both pharmacotherapeutic regimens.

Geometric pattern of the left ventricle

Group IMGroup IIBGroup IIIDχ2p
baselineConcentric remodeling5 (20%)5 (20%)4 (16%)0,71> 0,05
Concentric hypertrophy13 (52%)15 (60%)14 (56%)
Excentric hypertrophy7 (28%)5 (20%)7 (28%)
Normal geometry---
6 monthsConcentric remodeling3 (12%)7 (28%)7 (28%)4,61< 0,05
Concentric hypertrophy13 (52%)13 (52%)10 (40%)
Excentric hypertrophy8 (32%)5 (20%)5 (20%)
Normal geometry1 (4%)-3 (12%)

Contributors